2016
DOI: 10.1097/mcc.0000000000000274
|View full text |Cite
|
Sign up to set email alerts
|

Current and future status of extracorporeal life support for respiratory failure in adults

Abstract: ECMO is the next step in the algorithm for management of severe respiratory failure unresponsive to conventional care.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
20
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 19 publications
0
20
0
Order By: Relevance
“…VV-ECMO is indicated in patients with severe respiratory failure that is refractory to optimal mechanical ventilation and medical therapy (5). ECMO for respiratory failure in adults is usually managed with a VV configuration, i.e., blood is drained from the right atrium (RA) or superior vena cava (SVC) and inferior vena cava (IVC) and returned into the RA (6).…”
Section: Indications For Vv-ecmomentioning
confidence: 99%
“…VV-ECMO is indicated in patients with severe respiratory failure that is refractory to optimal mechanical ventilation and medical therapy (5). ECMO for respiratory failure in adults is usually managed with a VV configuration, i.e., blood is drained from the right atrium (RA) or superior vena cava (SVC) and inferior vena cava (IVC) and returned into the RA (6).…”
Section: Indications For Vv-ecmomentioning
confidence: 99%
“…In the last 10-15 years, the application of ECLS has evolved to a mid-term support with awake and spontaneously breathing patients treated in the ICU. 4 Again, this development was supported by technological advances, specifically in the field of oxygenators and pumps, 32 and by novel double-lumen cannulae, making ECLS simpler and safer. 4 As a result, the use of ECLS increased by 433% in the US from 2006 to 2011.…”
Section: Introductionmentioning
confidence: 99%
“…Extracorporeal membrane oxygenation (ECMO) is a mobile extracorporeal life support device that provides temporary, complete cardiopulmonary function support [ 3 ]. The respiratory support mode (veno-venous ECMO) gains valuable time to improve pulmonary functions and transition into isolated mechanical ventilation by enhancing oxygenation without increasing average alveolar pressure [ 4 , 5 ]. Positive results reported in a recent multi-central, randomized controlled trial [ 6 ] and subsequent success during an influenza A/H1N1 panepidemic [ 7 9 ] has consistently demonstrated that an ECMO-based management protocol significantly improves survival compared to conventional mechanical ventilation.…”
Section: Introductionmentioning
confidence: 99%